Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Mersana Therapeutics Inc (NASDAQ: MRSN) closed at $0.62 up 0.68% from its previous closing price of $0.61. In other words, the price has increased by $0.68 from its previous closing price. On the day, 7.69 million shares were traded. MRSN stock price reached its highest trading level at $0.6273 during the session, while it also had its lowest trading level at $0.58.
Ratios:
For a deeper understanding of Mersana Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.35 and its Current Ratio is at 2.35. In the meantime, Its Debt-to-Equity ratio is 30.00 whereas as Long-Term Debt/Eq ratio is at 15.51.
On March 19, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $5.
Wedbush Upgraded its Neutral to Outperform on February 29, 2024, whereas the target price for the stock was revised from $2 to $7.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 16 ’25 when Mandelia Ashish sold 3,554 shares for $0.58 per share. The transaction valued at 2,061 led to the insider holds 57,519 shares of the business.
Protopapas Anna sold 8,637 shares of MRSN for $5,009 on Jan 16 ’25. The Director now owns 168,041 shares after completing the transaction at $0.58 per share. On Jan 16 ’25, another insider, Lowinger Timothy B, who serves as the SVP, Chief Sci.&Tech. Officer of the company, sold 8,048 shares for $0.58 each. As a result, the insider received 4,668 and left with 257,673 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRSN now has a Market Capitalization of 76417512. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.19 while its Price-to-Book (P/B) ratio in mrq is 72.44.
Stock Price History:
The Beta on a monthly basis for MRSN is 1.44, which has changed by -0.7804965 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, MRSN has reached a high of $6.28, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is -66.90%, while the 200-Day Moving Average is calculated to be -71.20%.
Shares Statistics:
For the past three months, MRSN has traded an average of 2.98M shares per day and 12673920 over the past ten days. A total of 122.87M shares are outstanding, with a floating share count of 86.51M. Insiders hold about 29.93% of the company’s shares, while institutions hold 59.67% stake in the company. Shares short for MRSN as of 1735603200 were 8849970 with a Short Ratio of 2.97, compared to 1732838400 on 8752309. Therefore, it implies a Short% of Shares Outstanding of 8849970 and a Short% of Float of 9.4.
